drugset / Trial / NCT06554184
HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is aimed to evaluate the efficacy and safety of HR20013 versus palonosetron for nausea and vomiting associated with moderate emetic risk anticancer agents
Timeline
- Start
- 2024-09-03
- Primary completion
- 2025-07-28
- Completion
- 2025-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR20013 | Other / unclassified | — | — |
| Comparator | Palonosetron | Other / unclassified | — | — |
| Comparator | Dexamethasone | Small molecule | — | — |